Smith & Nephew plc develops, manufactures, and distributes medical devices and services across orthopedics, sports medicine, and advanced wound management. The company designs and markets knee and hip implants for joint replacement and revision procedures, trauma products for fracture stabilization and deformity correction, and sports medicine solutions for minimally invasive joint repair. Its product range includes arthroscopic enabling technologies such as cameras, fluid management systems, and tissue resection devices, alongside ear, nose, and throat solutions.
The Advanced Wound Management segment encompasses products for treating acute and chronic wounds, including negative pressure wound therapy systems, hydrosurgery systems, and regenerative medicine offerings such as skin and bone graft substitutes. The company also supplies bioactive technologies for wound debridement and dermal repair. These three segments—Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management—represent the company's primary revenue streams.
Headquartered in Watford, United Kingdom, Smith & Nephew operates globally with approximately 17,000 full-time employees. The company serves healthcare providers across developed and emerging markets, with significant operations in the United States and internationally. Founded in 1856, the company is listed on the New York Stock Exchange.
No 10-K filings found.